Abstract
The long-term evolution of Hu antibody (Hu-Ab) titers in patients with paraneoplastic neurologic syndromes (PNSs) is not known. Described is the evolution of Hu-Ab titers in 35 patients with PNS with a median follow-up of 32 months (range 6 to 108 months). No correlation was observed between Hu-Ab titers and neurologic outcome, tumor evolution, or type of treatment. Serial Hu-Ab determinations are not useful for monitoring the clinical outcome of patients with PNS.
| Original language | English |
|---|---|
| Pages (from-to) | 1947-1949 |
| Number of pages | 3 |
| Journal | Neurology |
| Volume | 63 |
| Issue number | 10 |
| Publication status | Published - Nov 23 2004 |
Fingerprint
ASJC Scopus subject areas
- Neuroscience(all)
Cite this
Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes. / Lladó, A.; Mannucci, P.; Carpentier, A. F.; Paris, S.; Blanco, Y.; Saiz, A.; Delattre, J. Y.; Graus, F.
In: Neurology, Vol. 63, No. 10, 23.11.2004, p. 1947-1949.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes
AU - Lladó, A.
AU - Mannucci, P.
AU - Carpentier, A. F.
AU - Paris, S.
AU - Blanco, Y.
AU - Saiz, A.
AU - Delattre, J. Y.
AU - Graus, F.
PY - 2004/11/23
Y1 - 2004/11/23
N2 - The long-term evolution of Hu antibody (Hu-Ab) titers in patients with paraneoplastic neurologic syndromes (PNSs) is not known. Described is the evolution of Hu-Ab titers in 35 patients with PNS with a median follow-up of 32 months (range 6 to 108 months). No correlation was observed between Hu-Ab titers and neurologic outcome, tumor evolution, or type of treatment. Serial Hu-Ab determinations are not useful for monitoring the clinical outcome of patients with PNS.
AB - The long-term evolution of Hu antibody (Hu-Ab) titers in patients with paraneoplastic neurologic syndromes (PNSs) is not known. Described is the evolution of Hu-Ab titers in 35 patients with PNS with a median follow-up of 32 months (range 6 to 108 months). No correlation was observed between Hu-Ab titers and neurologic outcome, tumor evolution, or type of treatment. Serial Hu-Ab determinations are not useful for monitoring the clinical outcome of patients with PNS.
UR - http://www.scopus.com/inward/record.url?scp=8844240580&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=8844240580&partnerID=8YFLogxK
M3 - Article
C2 - 15557520
AN - SCOPUS:8844240580
VL - 63
SP - 1947
EP - 1949
JO - Neurology
JF - Neurology
SN - 0028-3878
IS - 10
ER -